If you feel the medication is losing its impact toward the end of the week, talk to your provider about adjusting your dosage or lifestyle habits instead of changing your injection day
The GLP1 receptor agonist was better than the sulfonylurea which was better than DPP-4 inhibitor in glycemic control (17)
(2) Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA
However, ondansetron is a 5-HT3 receptor antagonist that works in the chemoreceptor trigger zone of the brain, whereas semaglutide acts primarily on GLP-1 pathways in the gut and central nervous system, so combining them addresses nausea through different mechanisms
Most DPP4is exhibit low and reversible plasma protein binding (ranging from 9.3% to 38%), except linagliptin (70%) and alogliptin (~100%)
In sum, the successful achievement of oral bioavailability for peptides must overcome the pH challenges of the stomach, a host of attacking peptidases in the GI lumen and brush border, low epithelial permeability, as well as the liver first pass effect (Figure 1)
